This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hezareh, M.
Right arrow Articles by Parren, P. W. H. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hezareh, M.
Right arrow Articles by Parren, P. W. H. I.

 Previous Article  |  Next Article 

Journal of Virology, December 2001, p. 12161-12168, Vol. 75, No. 24
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.24.12161-12168.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Effector Function Activities of a Panel of Mutants of a Broadly Neutralizing Antibody against Human Immunodeficiency Virus Type 1

Marjan Hezareh,1 Ann J. Hessell,1 Richard C. Jensen,1 Jan G. J. van de Winkel,2 and Paul W. H. I. Parren1,*

Department of Immunology, The Scripps Research Institute, La Jolla, California,1 and Department of Immunology and Genmab, University Medical Center Utrecht, Utrecht, The Netherlands2

Received 3 July 2001/Accepted 20 September 2001

The human antibody immunoglobulin G1 (IgG1) b12 neutralizes a broad range of human immunodeficiency virus-type 1 (HIV-1) isolates in vitro and is able to protect against viral challenge in animal models. Neutralization of free virus, which is an antiviral activity of antibody that generally does not require the antibody Fc fragment, likely plays an important role in the protection observed. The role of Fc-mediated effector functions, which may reduce infection by inducing phagocytosis and lysis of virions and infected cells, however, is less clear. To investigate this role, we constructed a panel of IgG1 b12 mutants with point mutations in the second domain of the antibody heavy chain constant region (CH2). These mutations, as expected, did not affect gp120 binding or HIV-1 neutralization. IgG1 b12 mediated strong antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) of HIV-1-infected cells, but these activities were reduced or abrogated for the antibody mutants. Two mutants were of particular interest. K322A showed a twofold reduction in Fcgamma R binding affinity and ADCC, while C1q binding and CDC were abolished. A double mutant (L234A, L235A) did not bind either Fcgamma R or C1q, and both ADCC and CDC functions were abolished. In this study, we confirmed that K322 forms part of the C1q binding site in human IgG1 and plays an important role in the molecular interactions leading to complement activation. Less expectedly, we demonstrate that the lower hinge region in human IgG1 has a strong modulating effect on C1q binding and CDC. The b12 mutants K322A and L234A, L235A are useful tools for dissecting the in vivo roles of ADCC and CDC in the anti-HIV-1 activity of neutralizing antibodies.

* Corresponding author. Mailing address: Department of Immunology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., IMM2, La Jolla, CA 92037. Phone: (858) 784-8602. Fax: (858) 784-8360. E-mail: parren{at}scripps.edu.

Journal of Virology, December 2001, p. 12161-12168, Vol. 75, No. 24
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.24.12161-12168.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Perez, L. G., Costa, M. R., Todd, C. A., Haynes, B. F., Montefiori, D. C. (2009). Utilization of Immunoglobulin G Fc Receptors by Human Immunodeficiency Virus Type 1: a Specific Role for Antibodies against the Membrane-Proximal External Region of gp41. J. Virol. 83: 7397-7410 [Abstract] [Full Text]  
  • Geiben-Lynn, R., Greenland, J. R., Frimpong-Boateng, K., van Rooijen, N., Hovav, A.-H., Letvin, N. L. (2008). CD4+ T lymphocytes mediate in vivo clearance of plasmid DNA vaccine antigen expression and potentiate CD8+ T-cell immune responses. Blood 112: 4585-4590 [Abstract] [Full Text]  
  • Machida, K., Kondo, Y., Huang, J. Y., Chen, Y.-C., Cheng, K. T.-H., Keck, Z., Foung, S., Dubuisson, J., Sung, V. M.-H., Lai, M. M. C. (2008). Hepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope Protein. J. Virol. 82: 6711-6720 [Abstract] [Full Text]  
  • Greenland, J. R., Geiben, R., Ghosh, S., Pastor, W. A., Letvin, N. L. (2007). Plasmid DNA Vaccine-Elicited Cellular Immune Responses Limit In Vivo Vaccine Antigen Expression through Fas-Mediated Apoptosis. J. Immunol. 178: 5652-5658 [Abstract] [Full Text]  
  • Florese, R. H., Van Rompay, K. K. A., Aldrich, K., Forthal, D. N., Landucci, G., Mahalanabis, M., Haigwood, N., Venzon, D., Kalyanaraman, V. S., Marthas, M. L., Robert-Guroff, M. (2006). Evaluation of Passively Transferred, Nonneutralizing Antibody-Dependent Cellular Cytotoxicity-Mediating IgG in Protection of Neonatal Rhesus Macaques against Oral SIVmac251 Challenge. J. Immunol. 177: 4028-4036 [Abstract] [Full Text]  
  • Forthal, D. N., Landucci, G., Cole, K. S., Marthas, M., Becerra, J. C., Van Rompay, K. (2006). Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells.. J. Virol. 80: 9217-9225 [Abstract] [Full Text]  
  • Dall'Acqua, W. F., Cook, K. E., Damschroder, M. M., Woods, R. M., Wu, H. (2006). Modulation of the Effector Functions of a Human IgG1 through Engineering of Its Hinge Region. J. Immunol. 177: 1129-1138 [Abstract] [Full Text]  
  • Hinton, P. R., Xiong, J. M., Johlfs, M. G., Tang, M. T., Keller, S., Tsurushita, N. (2006). An Engineered Human IgG1 Antibody with Longer Serum Half-Life. J. Immunol. 176: 346-356 [Abstract] [Full Text]  
  • Tsuchihashi, S.-i., Fondevila, C., Shaw, G. D., Lorenz, M., Marquette, K., Benard, S., Shen, X.-D., Ke, B., Busuttil, R. W., Kupiec-Weglinski, J. W. (2006). Molecular Characterization of Rat Leukocyte P-Selectin Glycoprotein Ligand-1 and Effect of Its Blockade: Protection from Ischemia-Reperfusion Injury in Liver Transplantation. J. Immunol. 176: 616-624 [Abstract] [Full Text]  
  • Jegerlehner, A., Schmitz, N., Storni, T., Bachmann, M. F. (2004). Influenza A Vaccine Based on the Extracellular Domain of M2: Weak Protection Mediated via Antibody-Dependent NK Cell Activity. J. Immunol. 172: 5598-5605 [Abstract] [Full Text]  
  • Nishimura, Y., Igarashi, T., Haigwood, N. L., Sadjadpour, R., Donau, O. K., Buckler, C., Plishka, R. J., Buckler-White, A., Martin, M. A. (2003). Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: Implications for HIV-1 vaccine development. Proc. Natl. Acad. Sci. USA 100: 15131-15136 [Abstract] [Full Text]  
  • Gaboriaud, C., Juanhuix, J., Gruez, A., Lacroix, M., Darnault, C., Pignol, D., Verger, D., Fontecilla-Camps, J. C., Arlaud, G. J. (2003). The Crystal Structure of the Globular Head of Complement Protein C1q Provides a Basis for Its Versatile Recognition Properties. J. Biol. Chem. 278: 46974-46982 [Abstract] [Full Text]  
  • Lopez-Bueno, A., Mateu, M. G., Almendral, J. M. (2003). High Mutant Frequency in Populations of a DNA Virus Allows Evasion from Antibody Therapy in an Immunodeficient Host. J. Virol. 77: 2701-2708 [Abstract] [Full Text]  
  • Villinger, F., Mayne, A. E., Bostik, P., Mori, K., Jensen, P. E., Ahmed, R., Ansari, A. A. (2002). Evidence for Antibody-Mediated Enhancement of Simian Immunodeficiency Virus (SIV) Gag Antigen Processing and Cross Presentation in SIV-Infected Rhesus Macaques. J. Virol. 77: 10-24 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»